Welcome To The Resverlogix HUB On AGORACOM

**Apabetalone (RVX-208) Currently Being Tested in a Phase 3 BETonMACE Trial and a Phase 2 Kidney Trial is Planned for 2017**



Namaste Enters Into Non-Binding LOI With CannMart, a Late Stage ACMPR Applicant

  • Namaste will purchase all of the issued and outstanding shares in the capital of CannMart, a late stage applicant under the Access to Cannabis for Medical Purposes Regulations
  • CannMart submitted its application to become a “sales only” licensed producer of medical cannabis


Hub On AGORACOM/ Read Release 

Message: A few comments

Interesting summary tada, my estimations have come out somewhat similar to yours (not quite as high on the high end) and the company's own NPV chart would suggest the correct neighbourhood (even more when you repeat the exercise for CKD). In any event thanks.  I revisited clinical trials.gov which I was led to believe were outside dates and it says final data collection for primary outcome is sept 2018 so I guess we'll know when we know. 

New Message
Please login to post a reply